Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of EnterobacterSTEFFEE, C. H; WASILAUSKAS, B. L.Chemotherapy (Basel). 1992, Vol 38, Num 5, pp 291-296, issn 0009-3157Article

Tracking laboratory contamination by using a Bacillus cereus pseudoepidemic as an exampleMORRELL, R. M; WASILAUSKAS, B. L.Journal of clinical microbiology (Print). 1992, Vol 30, Num 6, pp 1469-1473, issn 0095-1137Article

Clinical use of rifampicin during routine reporting of rifampicin susceptibilities : a lesson in selective reporting of antimicrobial susceptibility dataSTEFFEE, C. H; MORRELL, R. M; WASILAUSKAS, B. L et al.Journal of antimicrobial chemotherapy (Print). 1997, Vol 40, Num 4, pp 595-598, issn 0305-7453Article

An evaluation of the necessity of 24-hour incubation for oxacillin minimum inhibitory concentrationsWASILAUSKAS, B. L; MORRELL, R. M.American journal of clinical pathology. 1996, Vol 105, Num 4, pp 380-383, issn 0002-9173Conference Paper

Disseminated gonococcal infection caused by chromosomally mediated penicillin-resistant organismsSTRADER, K. W; WISE, C. M; WASILAUSKAS, B. L et al.Annals of internal medicine. 1986, Vol 104, Num 3, pp 365-366, issn 0003-4819Article

The use of C-reactive protein from cerebrospinal fluid for differentiating meningitis from other central nervous system diseasesABRAMSON, J. S; HAMPTON, K. D; BABU, S et al.The Journal of infectious diseases. 1985, Vol 151, Num 5, pp 854-858, issn 0022-1899Article

Use of the Directigen latex agglutination test for detection of Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis antigens in cerebrospinal fluid from meningitis patientsSIPPEL, J. E; HIDER, P. A; CONTRONI, G et al.Journal of clinical microbiology (Print). 1984, Vol 20, Num 5, pp 884-886, issn 0095-1137Article